| Dead Cas systems: types, principles, and applications S Brezgin, A Kostyusheva, D Kostyushev, V Chulanov International journal of molecular sciences 20 (23), 6041, 2019 | 111 | 2019 |
| CRISPR-Cas systems for diagnosing infectious diseases VC Anastasiya Kostyusheva, Sergey Brezgin , Yurii Babin, Irina Vasilyeva ... Methods, 2021 | 83* | 2021 |
| Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus D Kostyushev, S Brezgin, A Kostyusheva, D Zarifyan, I Goptar, ... Cellular and Molecular Life Sciences 76 (9), 1779-1794, 2019 | 72 | 2019 |
| Nanomedicine for increasing the oral bioavailability of cancer treatments A Parodi, P Buzaeva, D Nigovora, A Baldin, D Kostyushev, V Chulanov, ... Journal of Nanobiotechnology 19, 1-19, 2021 | 60 | 2021 |
| Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9 D Kostyushev, A Kostyusheva, S Brezgin, D Zarifyan, A Utkina, I Goptar, ... Scientific reports 9 (1), 1847, 2019 | 51 | 2019 |
| Введение в предиктивно-превентивную медицину: опыт прошлого и реалии дня завтрашнего ТА Бодрова, ДС Костюшев, ЕН Антонова, ДА Гнатенко, МО Бочарова, ... Вестник Российской академии медицинских наук 68 (1), 58-64, 2013 | 46 | 2013 |
| Gene Editing by Extracellular Vesicles VC Dmitry Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, Valery Smirnov ... International Journal of Molecular Sciences 21 (19), 7362, 2020 | 40* | 2020 |
| Протеомика как фундаментальный инструмент доклинического скрининга, верификации анализов и оценки применяемой терапии СВ Сучков, ДА Гнатенко, ДС Костюшев, СА Крынский, МА Пальцев Вестник Российской академии медицинских наук 68 (1), 65-71, 2013 | 37 | 2013 |
| Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification A Kostyusheva, S Brezgin, D Glebe, D Kostyushev, V Chulanov Emerging Microbes & Infections 10 (1), 2264-2275, 2021 | 36 | 2021 |
| HIV‐1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS‐Dependent Upregulation of Twist E Bayurova, J Jansons, D Skrastina, O Smirnova, D Mezale, ... Oxidative Medicine and Cellular Longevity 2019 (1), 6016278, 2019 | 27 | 2019 |
| Introduction into PPPM as a new paradigm of public health service: an integrative view TA Bodrova, DS Kostyushev, EN Antonova, S Slavin, DA Gnatenko, ... EPMA Journal 3, 1-11, 2012 | 27 | 2012 |
| Anticancer nanotherapeutics in clinical trials: The work behind clinical translation of nanomedicine A Parodi, EP Kolesova, MV Voronina, AS Frolova, D Kostyushev, ... International Journal of Molecular Sciences 23 (21), 13368, 2022 | 24 | 2022 |
| ATM and ATR expression potentiates HBV replication and contributes to reactivation of HBV infection upon DNA damage A Kostyusheva, S Brezgin, E Bayurova, I Gordeychuk, M Isaguliants, ... Viruses 11 (11), 997, 2019 | 22 | 2019 |
| Biomimetic approaches for targeting tumor-promoting inflammation A Parodi, D Kostyushev, S Brezgin, A Kostyusheva, T Borodina, R Akasov, ... Seminars in Cancer Biology 86, 555-567, 2022 | 21 | 2022 |
| Small molecular inhibitors of DNA double strand break repair pathways increase the ANTI-HBV activity of CRISPR/Cas9 AP Kostyusheva, DS Kostyushev, SA Brezgin, DN Zarifyan, EV Volchkova, ... Molecular Biology 53, 274-285, 2019 | 21 | 2019 |
| Clinical implications of hepatitis B virus RNA and covalently closed circular DNA in monitoring patients with chronic hepatitis B today with a gaze into the future: the field … A Kostyusheva, D Kostyushev, S Brezgin, E Volchkova, V Chulanov Genes 9 (10), 483, 2018 | 18 | 2018 |
| Technological aspects of manufacturing and analytical control of biological nanoparticles S Brezgin, A Parodi, A Kostyusheva, N Ponomareva, A Lukashev, ... Biotechnology Advances 64, 108122, 2023 | 16 | 2023 |
| Proteomics as a fundamental tool for subclinical screening, tests verification and assessment of applied therapy SV Suchkov, DS Kostushev, SA Krynskii, DA Gnatenko, MA Pal'tsev Annals of the Russian academy of medical sciences 68 (1), 65-71, 2013 | 16 | 2013 |
| Immunity and viral infections: modulating antiviral response via CRISPR–Cas systems S Brezgin, A Kostyusheva, E Bayurova, E Volchkova, V Gegechkori, ... Viruses 13 (7), 1373, 2021 | 15 | 2021 |
| Replenishment of hepatitis B virus cccDNA pool is restricted by baseline expression of host restriction factors in vitro S Brezgin, A Kostyusheva, E Bayurova, I Gordeychuk, M Isaguliants, ... Microorganisms 7 (11), 533, 2019 | 14 | 2019 |
Vladimir ChulanovCentral Research Institute of Epidemiology在 rcvh.ru 的电子邮件经过验证
